Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The endo question, for now, is secondary to these established indications
Expand into niche indications: Tap into segments where small molecules are less competitive, such as NASH, Alzheimers disease and cardiovascular protection
From Medicaid data publicly available, there is no way yet to disentangle how much of the growing use of GLP-1s is related to treatment for diabetes, cardiovascular disease, or sleep apnea versus obesity, or a combination
It's regulated under DSHEA, not the FDA drug approval pathway
The linear peptide is covalently bound to a C20 fatty diacid moiety at the side chain of the Lys20 amino acid ( Figure 2 depicts the amino acid sequence of tirzepatide in comparison to GLP-1, GIP as well as the GLP-1RA exendin-4 (exenatide)
The most appropriate option is determined during your consultation
US$ 23.03
US$ 27.71
US$ 28.26
US$ 25.60
US$ 24.59
US$ 22.49
US$ 27.80
US$ 29.26
US$ 23.83
US$ 29.14
US$ 24.13
US$ 20.03
